Sign up to save your podcasts
Or
Share Adjuvant HD Cisplatin-RT For High Risk Head & Neck Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Adjuvant HD Cisplatin-RT For High Risk Head & Neck Cancer
The Landmarks of OncoPharm series returns to discuss 2 landmark studies (and 1 editorial) in head & neck cancer.
Editorial: https://ascopubs.org/doi/pdf/10.1200/JCO.22.00274
EUORTC Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032641
Intergroup Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032646
View all episodes
By John Bossaer
4.9
185185 ratings
The Landmarks of OncoPharm series returns to discuss 2 landmark studies (and 1 editorial) in head & neck cancer.
Editorial: https://ascopubs.org/doi/pdf/10.1200/JCO.22.00274
EUORTC Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032641
Intergroup Study: https://www.nejm.org/doi/full/10.1056/NEJMoa032646
More shows like OncoPharm
View all
JAMA Clinical Reviews
503 Listeners
The Daily
113,219 Listeners
Up First from NPR
57,056 Listeners
Armchair Expert with Dax Shepard
69,763 Listeners
ASCO Guidelines
46 Listeners
The Peter Attia Drive
8,723 Listeners
OncLive® On Air
22 Listeners
Raising Good Humans
1,897 Listeners
Oncology Today with Dr Neil Love
58 Listeners
Huberman Lab
29,392 Listeners
The Money with Katie Show
1,561 Listeners
Two Onc Docs
195 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
46 Listeners
WolverHeme Happy Hour
30 Listeners
Good Hang with Amy Poehler
13,535 Listeners